Comment on

• Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia.

  Davidson MH, McGarry T, Bettis R, Melani L, Lipka LJ, LeBeaut AP, Suresh R, Sun S, Veltri EP. Davidson MH, et al. J Am Coll Cardiol. 2002 Dec 18;40(12):2125-34. doi: 10.1016/s0735-1097(02)02610-4. J Am Coll Cardiol. 2002. PMID: 12505224 Clinical Trial.
• Nephrotoxic effects in high-risk patients undergoing angiography.

  Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ; Nephrotoxicity in High-Risk Patients Study of Iso-Osmolar and Low-Osmolar Non-Ionic Contrast Media Study Investigators. Aspelin P, et al. N Engl J Med. 2003 Feb 6;348(6):491-9. doi: 10.1056/NEJMoa021833. N Engl J Med. 2003. PMID: 12571256 Clinical Trial.
• Effects of ximelagatran, an oral direct thrombin inhibitor, r-hirudin and enoxaparin on thrombin generation and platelet activation in healthy male subjects.

  Sarich TC, Wolzt M, Eriksson UG, Mattsson C, Schmidt A, Elg S, Andersson M, Wollbratt M, Fager G, Gustafsson D. Sarich TC, et al. J Am Coll Cardiol. 2003 Feb 19;41(4):557-64. doi: 10.1016/s0735-1097(02)02868-1. J Am Coll Cardiol. 2003. PMID: 12598065 Clinical Trial.
• Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18.

  Morrow DA, de Lemos JA, Sabatine MS, Murphy SA, Demopoulos LA, DiBattiste PM, McCabe CH, Gibson CM, Cannon CP, Braunwald E. Morrow DA, et al. J Am Coll Cardiol. 2003 Apr 16;41(8):1264-72. doi: 10.1016/s0735-1097(03)00168-2. J Am Coll Cardiol. 2003. PMID: 12706919 Clinical Trial.